Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.
By S. Rashid, S. Corbineau, N. Hannan, S. Marciniak, E. Miranda, G. Alexander, I. Huang-Doran, Julian L. Griffin, L. Åhrlund-Richter, J. Skepper and 4 more. Journal of Clinical Investigation, 2010
602 citations recorded by the source corpus.
Subfields: Molecular Biology, Surgery
View Paper: https://www.semanticscholar.org/paper/4724c49eb2ff897876c2464d9970fd21746526ad
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Yichen Shi
- P. Kirwan
- Frederick J. Livesey
- James C. Smith
- H. Robinson
Citations in the corpus
- Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver (2015, unknown): “The possibility of differentiating hESC or reprogrammed fibroblasts (iPS) into almost any differentiated cell type, from neurons to hepatocytes, has allowed modeling of many human genetic diseases, including A1AT-D (Rashid et al., 2010).”
- Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses (2012, background): “Nichols, Cambridge Centre for Stem Cell Research) and human iPS cell lines (BBHX, CRL and JR”